ArticleFrontiers in oncology2025
Case Report: Pulmonary sclerosing pneumocytoma mimicking as a neuroendocrine tumor on
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Symptomatic Sclerosing Pneumocytoma of Lung: A Diagnostic Challenge with Diverse Morphological Patterns.Iranian journal of pathology · 2026Article
- A Sheep in Wolf's Clothing: Pulmonary Sclerosing Pneumocytoma Mimicking Malignant Neoplasm.Annals of thoracic surgery short reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary sclerosing pneumocytoma (PSP) is a relatively rare benign lung tumor, and it is difficult to obtain an accurate diagnosis before surgery. Herein, we present a case of 34-year-old woman who came to our hospital for medical help due to cough and sputum for one month. She underwent a chest computed tomography (CT) scan which revealed a circular soft tissue density shadow in the upper lobe of the left lung. A needle biopsy was subsequently performed which revealed a probable lung carcinoid. To further evaluate the nature of the mass and determine a treatment plan, the patient subsequently underwent dual nuclide tracer including fluorine-18 labeled fluorodeoxyglucose (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.